www.medicsight.com
Medicsight Plc is a UK-headquartered research driven developer of computer-aided detection (CAD) and image analysis software for the medical imaging market, engaged in the development and commercialization of medical imaging software, which analyses Computer Tomography (CT) scans for the early detection and measurement of colon cancer polyps and lung cancer lesions. The Company is also engaged in the research and development of other medical software applications and devices with potential applications in the medical imaging, detection and diagnosis sectors. On June 28, 2007, Medicsight PLC acquired the entire share capital of Medicexchange PTY Ltd from Medicexchange (International) Ltd.
Medicsight launches online ColonCAD visualisation product
MedicRead 3.0 Colon is Medicsight’s own visualisation platform, integrated with the ColonCAD software to help radiologists read computer tomography (CT) scans for the detection of colonic polyps, which may be the precursors of colon cancer.
The online product is making CAD accessible to the global radiology community.
Chief executive Allan Rowley said: “The launch of our online MedicRead 3.0 Colon platform provides the company with an additional revenue stream. It is the only visualisation workstation that can be accessed and downloaded online enabling the international radiology community to experience and take advantage of the clinical benefits of ColonCAD.”
Access to Medicsight's ColonCAD software is currently available through the company's partners' 3D visualisation platforms.
MedicRead 3.0 Colon is not currently available for sale in the US.
















